Schizophrenia.com
Efficacy and safety of evenamide, a glutamate modulator, added to a second-generation antipsychotic in inadequately/poorly responding patients with chronic schizophrenia:
News
everhopeful
December 22, 2024, 12:41pm
1
5 Likes
Related topics
Topic
Replies
Views
Activity
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics
News
0
67
January 31, 2026
Evenamide for Negative Symptoms in Schizophrenia - Moves on to Phase 3 Clinical Trials
News
2
2870
November 8, 2017
Can anyone explain to me the mechanism of action of evenamide and why it will or won't work?
Medications
13
1156
October 8, 2017
Newron presents encouraging interim results for evenamide in patients with Treatment-Resistant Schizophrenia
News
5
694
June 9, 2022
Newron TRS Study 6 Months’ Results: Evenamide Substantially Improves Patients to an Extent That They No Longer Meet Protocol Entry Criteria
News
11
651
October 12, 2023